Regression pattern of alpha fetoprotein level changed after treatment of malignant germ cell tumor.
OBJECTIVE
To identify the regression pattern of serum alpha fetoprotein in malignant germ cell tumors after initial chemotherapy


METHODS
This was a retrospective descriptive study. All patients with malignant germ cell tumor who had elevated serum alpha fetoprotein (AFP) and received adjuvant chemotherapy in Rajavithi Hospital between January 1984 and May 2007 were included.


RESULTS
Sixty patients with malignant germ cell tumor that met the study criteria were included. The median progression free interval (PFI) was 64.3 months and the median overall survival (OS) was 70.9 months. Four courses of chemotherapy was the average. AFP was first negative after a mean of course of three. Two more cycles were given as a maintenance course. The regression of AFP, between its level before the first and second courses was less than 0.015, associated with survival, accuracy about 70%, sensitivity 83.3%. The number of maintenance courses of chemotherapy was statistically affected to PFI and OS (p-value of 0.025, 0.003, respectively).


CONCLUSIONS
The regression of AFP is an independent prognostic factor in malignant germ cell tumor and may be a useful tool in the therapeutic management of these patients.
Department of Obstetrics and Gynecology, Rajavithi Hospital, Bangkok, Thailand. ssanersak@yahoo.com
Sukumarn
S
Sanersak
Nisa
N
Prueksritanond
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents; D002648:Child; D018450:Disease Progression; D005260:Female; D006305:Health Status Indicators; D006801:Humans; D008297:Male; D008875:Middle Aged; D009373:Neoplasms, Germ Cell and Embryonal / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology*; D011379:Prognosis; D012044:Regression Analysis; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D000509:alpha-Fetoproteins / Q000032:analysis*
D000970:Antineoplastic Agents; D000509:alpha-Fetoproteins